Chimeric immunomodulatory compounds and methods of using the same—III
KL Fearon, D Dina, SF Tuck - US Patent 7,785,610, 2010 - Google Patents
US7785610B2 - Chimeric immunomodulatory compounds and methods of using the same—III
- Google Patents US7785610B2 - Chimeric immunomodulatory compounds and methods of …
- Google Patents US7785610B2 - Chimeric immunomodulatory compounds and methods of …
Immunostimulatory nucleic acid molecules
Nucleic acids containing unmethylated CpG dinucleotides and therapeutic utilities based on
their ability to stimulate an immune response and to redirect a Th2 response to a Th1 …
their ability to stimulate an immune response and to redirect a Th2 response to a Th1 …
Methods related to immunostimulatory nucleic acid-induced interferon
G Hartmann, RL Bratzler, AM Krieg - US Patent 7,776,344, 2010 - Google Patents
US7776344B2 - Methods related to immunostimulatory nucleic acid-induced interferon -
Google Patents US7776344B2 - Methods related to immunostimulatory nucleic acid-induced …
Google Patents US7776344B2 - Methods related to immunostimulatory nucleic acid-induced …
Immunomodulatory oligonucleotides
AM Krieg, D Klinman, AD Steinberg - US Patent 8,309,527, 2012 - Google Patents
2,215,233 A 9, 1940 Ruskin 3,627,874 A 12/1971 Vella et al. 3,906,092 A 9, 1975 Hilleman
et al. 3,911,117 A 10, 1975 Ender 3,914.450 A 10, 1975 Robbins et al. 4,188,375 A 2f1980 …
et al. 3,911,117 A 10, 1975 Ender 3,914.450 A 10, 1975 Robbins et al. 4,188,375 A 2f1980 …
Immunostimulatory sequence oligonucleotides and methods of using the same
D Dina, KL Fearon, J Marshall - US Patent 7,745,606, 2010 - Google Patents
US7745606B2 - Immunostimulatory sequence oligonucleotides and methods of using the
same - Google Patents US7745606B2 - Immunostimulatory sequence oligonucleotides and …
same - Google Patents US7745606B2 - Immunostimulatory sequence oligonucleotides and …
Immunostimulatory nucleic acid molecules
Nucleic acids containing unmethylated CpG dinucleotides and therapeutic utilities based on
their ability to stimulate an immune response and to redirect a Th2 response to a Th1 …
their ability to stimulate an immune response and to redirect a Th2 response to a Th1 …
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
The invention relates to the therapeutic use of oligonucleotides as immunostimulatory
agents in immunotherapy applications. More particularly, the invention provides …
agents in immunotherapy applications. More particularly, the invention provides …
Immunostimulatory sequence oligonucleotides and methods of using the same
D Dina, KL Fearon, J Marshall - US Patent 8,158,768, 2012 - Google Patents
US PATENT DOCUMENTS 4,458,066 A 7, 1984 Caruthers et al. 4,650,675 A 3, 1987 Borel
et al. 4,849,513 A 7, 1989 Smith et al. 4,910,300 A 3, 1990 Urdea et al. 4,948,882 A 8, 1990 …
et al. 4,849,513 A 7, 1989 Smith et al. 4,910,300 A 3, 1990 Urdea et al. 4,948,882 A 8, 1990 …
Chimeric immunomodulatory compounds and methods of using the same-ll
K Fearon, D Dina, S Tuck - US Patent App. 10/177,826, 2003 - Google Patents
BACKGROUND 0.003 Reference to a publication in this section should not be construed as
an indication that the publication is prior art to the present invention. 0004. The type of …
an indication that the publication is prior art to the present invention. 0004. The type of …
Vaccine
RL Biemans, A Elouahabi - US Patent 8,846,080, 2014 - Google Patents
US8846080B2 - Vaccine - Google Patents US8846080B2 - Vaccine - Google Patents Vaccine
Download PDF Info Publication number US8846080B2 US8846080B2 US13/060,301 …
Download PDF Info Publication number US8846080B2 US8846080B2 US13/060,301 …